[1]    Jenul C, Horswill AR. Regulation of Staphylococcus aureus virulence. Microbiology spectrum. 2019;7(2):7.2. 29. https://doi.org/10.1128/microbiolspec.gpp3-0031-2018. 

Google Scholar 
[2]    Adams M, Moss M, McClure P. Food Microbiology, London, UK, Royal Society of Chemistry, 1995: 121-122. ISBN (Printed): 1849739609.

[3]    Cheung GY, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547-69. https://doi.org/10.1080/21505594.2021.1878688. 

Google Scholar 
[4]    Rasigade J-P, Dumitrescu O, Lina G. New epidemiology of Staphylococcus aureus infections. Clinical Microbiology and Infection. 2014;20(7):587-8. https://doi.org/10.1111/1469-0691.12718. 

Google Scholar 
[5]    Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler Jr VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clinical microbiology reviews. 2015;28(3):603-61. https://doi.org/10.1128/cmr.00134-14. 

Google Scholar 
[6]    Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H, et al. Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. International journal of antimicrobial agents. 2012; 39(4) :273-82. https://doi.org/10.1016/j.ijantimicag.2011.09.030.  

Google Scholar 
[7]    Rasmi AH, Ahmed EF, Darwish AMA, Gad GFM. Virulence genes distributed among Staphylococcus aureus causing wound infections and their correlation to antibiotic resistance. BMC Infectious Diseases. 2022;22(1):652. https://doi.org/10.1186/s12879-022-07624-8.  

Google Scholar 
[8]    Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSA problem. Microbiology spectrum. 2019; 7(2):10. https://doi.org/10.1128/microbiolspec.gpp3-0057-2018. 

Google Scholar 
[9]    Algammal AM, Hetta HF, Elkelish A, Alkhalifah DHH, Hozzein WN, Batiha GE-S, et al. Methicillin-Resistant Staphylococcus aureus (MRSA): one health perspective approach to the bacterium epidemiology, virulence factors, antibiotic-resistance, and zoonotic impact. Infection and Drug Resistance. 2020:3255-65. https://doi.org/10.2147/idr.s272733. 

Google Scholar 
[10]    Peacock SJ, Paterson GK. Mechanisms of methicillin resistance in Staphylococcus aureus. Annual review of biochemistry. 2015;84:577-601. https://doi.org/10.1146/annurev-biochem-060614-034516. 

Google Scholar 
[11]    Kitti T, Boonyonying K, Sitthisak S. Prevalence of methicillin-resistant Staphylococcus aureus among university students in Thailand. Southeast Asian Journal of Tropical Medicineand Public Health. 2011;42(6):1498. PMID: 22299421.

Google Scholar 
[12]    Prenafeta A, Sitjà M, Holmes MA, Paterson GK. Biofilm production characterization of mecA and mecC methicillin-resistant Staphylococcus aureus isolated from bovine milk in Great Britain. Journal of Dairy Science. 2014;97(8):4838-41. https://doi.org/10.3168/jds.2014-7986. 

Google Scholar 
[13]    Gajdács M, Zsoldiné Urbán E. Epidemiology and resistance trends of Staphylococcus aureus isolated from vaginal samples: a 10-year retrospective study in Hungary. Acta Dermatovenerologica Alpina, Pannonica et Adriatica. 2019;28(4):143-7. PMID: 31855266.

Google Scholar 
[14]    Azeez-Akande O. Global trend of methicillin-resistant Staphlococcus aureus and emerging challenges for control. African Journal of Clinical and Experimental Microbiology. 2010;11(3): 150-158. https://doi.org/10.4314/ajcem.v11i3.57771. 

Google Scholar 
[15]    Kadariya J, Smith TC, Thapaliya D. Staphylococcus aureus and staphylococcal food-borne disease: an ongoing challenge in public health. BioMed research international. 2014;2014: 1-9. https://doi.org/10.1155/2014/827965.  

Google Scholar 
[16]    Heaton CJ, Gerbig GR, Sensius LD, Patel V, Smith TC. Staphylococcus aureus epidemiology in wildlife: A systematic review. Antibiotics. 2020;9(2):89. https://doi.org/10.3390/antibiotics9020089. 

Google Scholar 
[17]    Shimizu M, Mihara T, Ohara J, Inoue K, Kinoshita M, Sawa T. Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia. Plos one. 2022;17(7):e0271115. https://doi.org/10.1371/journal.pone.0271115. 

Google Scholar 
[18]    Haag AF, Fitzgerald JR, Penadés JR. Staphylococcus aureus in Animals. Microbiology Spectrum. 2019;7(3):1-19. https://doi.org/10.1128/microbiolspec.gpp3-0060-2019. 

Google Scholar 
[19]    Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proceedings of the National Academy of Sciences. 2004; 101 (26): 9786-9791. https://doi.org/10.1073/pnas.0402521101.

Google Scholar 
[20]    Breurec S, Zriouil S, Fall C, Boisier P, Brisse S, Djibo S, et al. Epidemiology of methicillin-resistant Staphylococcus aureus lineages in five major African towns: emergence and spread of atypical clones. Clinical Microbiology and Infection. 2011;17(2):160-5. https://doi.org/10.1111/j.1469-0691.2010.03219.x.

Google Scholar 
[21]    Stegger M, Wirth T, Andersen PS, Skov RL, De Grassi A, Simões PM, et al. Origin and evolution of European community-acquired methicillin-resistant Staphylococcus aureus. MBio. 2014; 5 (5). https://doi.org/10.1128/mbio.01044-14.  

Google Scholar 
[22]    Abdulgader SM, Shittu AO, Nicol MP, Kaba M. Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic review. Frontiers in microbiology. 2015; 6:348. https://doi.org/10.3389/fmicb.2015.00348.  

Google Scholar 
[23]    Grema HA, Geidam YA, Gadzama GB, Ameh JA, Suleiman A. Methicillin resistant Staphylococcus aureus (MRSA): a review. Adv Anim Vet Sci. 2015;3(2):79-98. http://dx.doi.org/10.14737/journal.aavs/2015/3.2.79.98.

Google Scholar 
[24]    Fleming A. Penicillin. British medical journal. 1941; 2(4210): 386. https://doi.org/10.1136/bmj.2.4519.242. 

Google Scholar 
[25]    Buhner SH. Herbal antibiotics: natural alternatives for treating drug-resistant bacteria. New York, USA: Storey Publishing, LLC, 2012. ISBN (electronic): 978-1603429870. ISBN (printed): 1603429875.

Google Scholar 
[26]    Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: a review. Jama. 2019;321(2):188-99. https://doi.org/10.1001/jama.2018.19283.  

Google Scholar 
[27]    Bush K, Bradford PA. β-Lactams and β-lactamase inhibitors: an overview. Cold Spring Harbor perspectives in medicine. 2016;6(8). https://doi.org/10.1101/cshperspect.a025247. 

Google Scholar 
[28]    Lobanovska M, Pilla G. Focus: drug development: Penicillin’s discovery and antibiotic resistance: lessons for the future? The Yale journal of biology and medicine. 2017;90(1):135-145. PMID: 28356901.

Google Scholar 
[29]    Huttner A, Bielicki J, Clements MN, Frimodt-Møller N, Muller AE, Paccaud J-P, et al. Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage. Clinical Microbiology and Infection. 2020;26(7):871-9. https://doi.org/10.1016/j.cmi.2019.11.028. 

Google Scholar 
[30]    Khan DA, Banerji A, Bernstein JA, Bilgicer B, Blumenthal K, Castells M, et al. Cephalosporin allergy: current understanding and future challenges. The Journal of Allergy and Clinical Immunology: In Practice. 2019;7(7) :2105-2114. https://doi.org/10.1016/j.jaip.2019.06.001.  

Google Scholar 
[31]    Fröhlich C, Sørum V, Tokuriki N, Johnsen PJ, Samuelsen Ø. Evolution of β-lactamase-mediated cefiderocol resistance. Journal of Antimicrobial Chemotherapy. 2022; 77(9): 2429-2436. https://doi.org/10.1093/jac/dkac221.  

Google Scholar 
[32]    Moguet C, Gonzalez C, Sallustrau A, Gelhaye S, Naas T, Simon S, et al. Detection of expanded‐spectrum cephalosporin hydrolysis by lateral flow immunoassay. Microbial Biotechnology. 2022; 15(2):603-612. https://doi.org/10.1111/1751-7915.13892. 

Google Scholar 
[33]    Fernandez J, Jimenez-Rodriguez TW, Blanca-Lopez N. Classifying cephalosporins: from generation to cross-reactivity. Current Opinion in Allergy and Clinical Immunology. 2021; 21 (4): 346-354. https://doi.org/10.1097/aci.0000000000000755.  

Google Scholar 
[34]    El-Gamal MI, Brahim I, Hisham N, Aladdin R, Mohammed H, Bahaaeldin A. Recent updates of carbapenem antibiotics. European journal of medicinal chemistry. 2017; 131: 185-195. https://doi.org/10.1016/j.ejmech.2017.03.022. 

Google Scholar 
[35]    Potter RF, D’Souza AW, Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resistance Updates. 2016;29:30-46. https://doi.org/10.1016/j.drup.2016.09.002.  

Google Scholar 
[36]    Doi Y. Treatment options for carbapenem-resistant gram-negative bacterial infections. Clinical Infectious Diseases. 2019;69(Supplement_7):S565-S75. https://doi.org/10.1093/cid/ciz830. 

[37]    Brink AJ. Epidemiology of carbapenem-resistant Gram-negative infections globally. Current opinion in infectious diseases. 2019;32(6):609-16. https://doi.org/10.1097/qco.0000000000000608. 

Google Scholar 
[38]    Fei Z, Wu Q, Li L, Jiang Q, Li B, Chen L, et al. New synthesis for the monobactam antibiotic—LYS228. The Journal of Organic Chemistry. 2020; 85(11): 6854-6861. https://doi.org/10.1021/acs.joc.9b01916. 

Google Scholar 
[39]    Emeraud C, Escaut L, Boucly A, Fortineau N, Bonnin RA, Naas T, et al. Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-β-lactamase-producing Gram-negative bacteria. Antimicrobial agents and chemotherapy. 2019;63(5):10.1128/aac. 00010-19. https://doi.org/10.1128/aac.00010-19. 

Google Scholar 
[40]    Fiel S. Aerosolized antibiotics in cystic fibrosis: an update. Expert Rev Respir Med 8: 305–314. 2014. https://doi.org/10.1586/17476348.2014.896205. 

Google Scholar 
[41]    Lima LM, da Silva BNM, Barbosa G, Barreiro EJ. β-lactam antibiotics: An overview from a medicinal chemistry perspective. European journal of medicinal chemistry. 2020;208:112829. https://doi.org/10.1016/j.ejmech.2020.112829. 

Google Scholar 
[42]    Suarez C, Gudiol F. Beta-lactam antibiotics. Enfermedades infecciosas y microbiologia clinica. 2009;27(2):116-29. https://doi.org/10.1016/j.eimc.2008.12.001. 

Google Scholar 
[43]    Kotra LP, Mobashery S. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases. Archivum immunologiae et therapiae experimentalis. 1999;47(4):211-216. PMID: 10483868.

Google Scholar 
[44]    Malouin F, Bryan L. Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance. Antimicrobial agents and chemotherapy. 1986; 30(1): 1-5. https://doi.org/10.1128/aac.30.1.1. 

Google Scholar 
[45]    Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding proteins and β-lactam resistance. FEMS microbiology reviews. 2008;32(2):361-385. https://doi.org/10.1111/j.1574-6976.2007.00095.x.  

Google Scholar 
[46]    Shapiro AB. Investigation of β-lactam antibacterial drugs, β-lactamases, and penicillin-binding proteins with fluorescence polarization and anisotropy: a review. Methods and Applications in Fluorescence. 2016; 4(2): 024002. https://doi.org/10.1088/2050-6120/4/2/024002. 

Google Scholar 
[47]    Donowitz GR, Mandell GL. Beta-lactam antibiotics. New England Journal of Medicine. 1988; 318(7): 419-426. https://doi.org/10.1056/nejm198802183180706. 

Google Scholar 
[48]    Barber M. Methicillin-resistant staphylococci. Journal of clinical pathology. 1961; 14(4): 385. https://doi.org/10.1136/jcp.14.4.385. 

Google Scholar 
[49]    Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. New England Journal of Medicine. 1989;320(18):1188-1196. https://doi.org/10.1056/nejm198905043201806. 

Google Scholar 
[50]    Firth N, Jensen SO, Kwong SM, Skurray RA, Ramsay JP. Staphylococcal plasmids, transposable and integrative elements. Microbiology spectrum. 2018; 6(6). https://doi.org/10.1128/microbiolspec.gpp3-0030-2018. 

Google Scholar 
[51]    Zygmunt DJ, Stratton CW, Kernodle DS. Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrobial agents and chemotherapy. 1992;36(2):440-5. https://doi.org/10.1128/aac.36.2.440. 

Google Scholar 
[52]    Knowles JR. Penicillin resistance: the chemistry of. beta.-lactamase inhibition. Accounts of Chemical Research. 1985;18(4):97-104. https://doi.org/10.1021/ar00112a001. 

Google Scholar 
[53]    Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrobial agents and chemotherapy. 1995; 39(6): 1211-33. https://doi.org/10.1128/aac.39.6.1211. 

Google Scholar 
[54]    Maddux MS. Effects of ß‐Lactamase‐Mediated Antimicrobial Resistance: The Role of ß‐Lactamase Inhibitors. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 1991;11(2P2):40S-50S. PMID: 2041831.

Google Scholar 
[55]    Livermore DM, Brown DF. Detection of β-lactamase-mediated resistance. Journal of antimicrobial chemotherapy. 2001;48(suppl_1):59-64. https://doi.org/10.1093/jac/48.suppl_1.59. 

[56]    Clarke SR, Dyke KG. Studies of the operator region of the Staphylococcus aureus β-lactamase operon. Journal of Antimicrobial Chemotherapy. 2001;47(4):377-89. https://doi.org/10.1093/jac/47.4.377. 

Google Scholar 
[57]    PA W. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI document M100-S20. 2010. https://cir.nii.ac.jp/crid/1572261550694185984. 

[58]    Wu P-J, Shannon K, Phillips I. Mechanisms of hyperproduction of TEM-1 β-lactamase by clinical isolates of Escherichia coli. Journal of Antimicrobial Chemotherapy. 1995;36(6):927-39. https://doi.org/10.1093/jac/36.6.927. 

Google Scholar 
[59]    Lee N, Yuen K-Y, Kumana CR. Clinical role of β-lactam/β-lactamase inhibitor combinations. Drugs. 2003; 63: 1511-24. https://doi.org/10.2165/00003495-200363140-00006. 

Google Scholar 
[60]    Tortora GJ, Funke BR, Case CL. Microbiology: an introduction: San Fransisco, USA, Pearson Benjamin Cummings San Francisco, 2018. ISBN (Electronic): 978-0134605180. ISBN (Printed): 0134605187.

[61]    Kobayashi N, Wu H, Kojima K, Taniguchi K, Urasawa S, Uehara N, et al. Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiology & Infection. 1994;113(2):259-66. https://doi.org/10.1017/s0950268800051682. 

Google Scholar 
[62]    Ray C & Ryan K.J, Sherris Medical Microbiology: An Introduction to Infectiuos Disease, Chicago, USA, McGraw Hill Medical, 2003. ISBN (Electronic): 978-0838585290. ISBN (Printed): 0838585299.

Google Scholar 
[63]    Daum RS, Ito T, Hiramatsu K, Hussain F, Mongkolrattanothai K, Jamklang M, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. The Journal of infectious diseases. 2002;186(9):1344-7. https://doi.org/10.1086/344326.

Google Scholar 
[64]    Fey P, Said-Salim B, Rupp M, Hinrichs S, Boxrud D, Davis C, Kreiswirth BN, Schlievert PM. Comparative molecular analysis of community-or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy. 2003;47(1):196-203. https://doi.org/10.1128/aac.47.1.196-203.2003.

Google Scholar 

@article{issa,kovandilawerandmuhsin,mohammeddlshad2023,
 author = {Issa, Kovan Dilawer and Muhsin, Mohammed Dlshad},
 title = {Beta–Lactam Drug Resistance Pattern in Staphylococcus aureus Isolates: A Review},
 journal = {Eurasian J. Sci. Eng},
 volume = {9},
 number = {3},
 pages = {141-153},
 year = {2023}
}